AbbVie Inc. (NYSE:ABBV)

Bull and Bear

Top Analyst Upgrades and Downgrades: ARIAD, FedEx, Genpact, Suncor, Travelers, UPS and More

Stocks were trying to post a recovery on Thursday morning on the heels of three days worth of energy-related selling. Despite a relatively harsh drop, investors have proven over and ...
Read Full Story »
Monkey evil

Top Analyst Upgrades and Downgrades: Harley-Davidson, Lululemon, Nike, SunPower, Walmart and More

Stocks were trying to hold on to gains on Friday morning after a marginal gain in eurozone GDP indicates that quantitative easing is needed over there. The one lesson we ...
Read Full Story »
biotech

4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic

One sad trend that has exploded in the new millennium has been the increase in hepatitis C cases in the Unites States and around the world. One startling fact is ...
Read Full Story »
AT&T logo

The 7 Most Heavily Shorted NYSE Stocks

Here is a look at the seven stocks traded on the New York Stock Exchange with the largest number of shares held short as of October 15. Only one of ...
Read Full Story »
buy sell

UBS’s Big List of Quality Stocks to Buy Now

Needless to say, the destruction in the markets since the beginning of the fourth quarter has been painful. The solid firms on Wall Street are rolling up their sleeves and ...
Read Full Story »
Sprint USB device

Sprint Drops From the 5 Most Shorted NYSE Stocks

The five most shorted stocks on the New York Stock Exchange at the September 30 settlement date saw rising short interest during the two-week period. Sprint was the exception, with ...
Read Full Story »
NYSE-flag

AbbVie Joins the 5 Most Shorted NYSE Stocks

Overall, there was little movement among the most shorted stocks on the New York Stock Exchange between the August 29 and September 15 settlement dates, other than a surge in ...
Read Full Story »
Tax

Is Treasury Plan for Tax Inversion REALLY Trouble for Merger Stocks?

The U.S. Treasury has finally made its proposed effort to deal with the waves of corporate tax inversions that have created such a stir of late. The move is also ...
Read Full Story »
health care

U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks

For a variety of reasons, the cases of chronic hepatitis in the United States have surged dramatically over the past 20 years. Currently, it is estimated that more than 3.2 ...
Read Full Story »
Sprint USB device

Sprint Joins the 5 Most Shorted NYSE Stocks

Surges in short interest between the August 15 and August 29 settlement dates pushed Sprint into the top five and Kinder Morgan into the top 10 most shorted stocks on ...
Read Full Story »
180519466

Is Infinity Fully Valued Now, or Is More Upside Left?

Infinity Pharmaceuticals Inc. (NASDAQ: INFI) has seen its stock rise so much on a pact that you might just think it is a buyout. It turns out that the pact ...
Read Full Story »
Pills

Credit Suisse’s 4 Top Pharmaceutical Stocks to Buy for the Rest of 2014

While technology has dominated as the leading sector in the S&P 500 this year, currently up more than 20%, investors may be surprised to learn that pharmaceuticals have shown solid ...
Read Full Story »
Pills

AbbVie Earnings Take Back Seat to Shire Merger

AbbVie Inc. (NYSE: ABBV) reported second-quarter 2014 results before markets opened Friday. The pharmaceutical research firm posted adjusted diluted earnings per share (EPS) of $0.82 on revenues of $4.93 billion. ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, FireEye, JDSU Uniphase, Solar Stocks and More

Stocks were firm on Tuesday morning during a shortened week that actually will be full of economic reports. 24/7 Wall St. reviews dozens of analyst research reports each morning of ...
Read Full Story »
health care

Analyst Cancer and Biotech Stock Picks From ASCO

As the summer starts, a large agenda is out there for investors when it comes to top biotech and specialty pharmaceutical companies making announcements and presenting clinical data. The biggest ...
Read Full Story »